A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
Claire Newton(University of Pretoria), Michelle Lockley(University College Hospital), Jonathan Shamash(Queen Mary University of London), Amar Ahmad(Cancer Research UK), Krithika Murali(Royal Marsden NHS Foundation Trust), Susana Banerjee(Royal Marsden NHS Foundation Trust), Daniel M. Berney(Queen Mary University of London), Helen Hockings(St Bartholomew's Hospital), Jonathan A. Ledermann(London Cancer), Viola Liberale(Ospedale Maria Vittoria), Shah‐Jalal Sarker(Queen Mary University of London), Radha Graham(University College Hospital), Sara Stoneham(University College Hospital)
Cited by 63
Related Papers
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k